MetaCap

Xilio Therapeutics Insider Trades

NASDAQ: XLOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.56-0.085 (-1.11%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $43.95K
Sales
2 · $5.70K
Shares bought / sold
5.00K / 8.86K
Net activity
Net buying $38,254

Xilio Therapeutics insider activity

Over the last 12 months, Xilio Therapeutics insiders reported 7 transactions on SEC Form 4: 1 open-market purchase and 2 sales. Insiders bought $43,950 and sold $5,696 worth of stock, for net insider buying of $38,254. The largest seller was Frankenfield Christopher James, with $4,522 in reported sales.

The most recent filing shows Shannon James Samuel (Director) buying 5,000 shares at $8.79 on Mar 26, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put XLO's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

XLO insider transactions

Xilio Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Mar 26, 2026Shannon James SamuelDirectorBuy5,000$43.95KForm 4
Jan 2, 2026Brennan Kevin M.SVP, FINANCE AND ACCOUNTINGSale1,826$1.17KForm 4
Jan 2, 2026Frankenfield Christopher JamesChief Financial OfficerSale7,030$4.52KForm 4
Jan 1, 2026Russo RenePRESIDENT AND CEOOption exercise44,250—Form 4
Jan 1, 2026Brennan Kevin M.SVP, FINANCE AND ACCOUNTINGOption exercise5,000—Form 4
Jan 1, 2026Luptakova KatarinaCHIEF MEDICAL OFFICEROption exercise16,625—Form 4
Jan 1, 2026Frankenfield Christopher JamesChief Financial OfficerOption exercise19,375—Form 4
Jun 17, 2025Shannon James SamuelDirectorBuy25,000$17.21KForm 4
Jun 16, 2025Shannon James SamuelDirectorBuy45,000$30.87KForm 4
Jun 16, 2025Russo RenePRESIDENT AND CEOBuy36,289$24.68KForm 4
Jan 2, 2025Brennan Kevin M.SVP, FINANCE AND ACCOUNTINGSale1,803$1.77KForm 4
Jan 2, 2025Frankenfield Christopher JamesChief Financial OfficerSale6,954$6.84KForm 4
Jan 1, 2025Luptakova KatarinaCHIEF MEDICAL OFFICEROption exercise16,625—Form 4
Jan 1, 2025Russo RenePRESIDENT AND CEOOption exercise44,250—Form 4
Jan 1, 2025Brennan Kevin M.SVP, FINANCE AND ACCOUNTINGOption exercise5,000—Form 4
Jan 1, 2025Frankenfield Christopher JamesChief Financial OfficerOption exercise19,375—Form 4
Dec 18, 2024GILEAD SCIENCES, INC.10% OwnerBuy1,759,978$1.83MForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related